Glucosylceramide synthase inhibitors

Inventors: Elyse Bourque (Blaine, WA); Bradford Hirth (Framingham, MA); Renato Sklerj (West Newton, MA); Elina Makino (Winchester, MA); Fazeela Morshed (Waltham, MA); Lingyun Li (Waltham, MA); Paul Mason (Natick, MA); John P. Leonard (Manchester, NH); James Lillie (Wellesley, MA); Hanlan Liu (Lexington, MA); Mary A. Cromwell (Groton, MA); Bing Wang (Newton, MA); Thomas O'Shea (Wellesley, MA)

Assignee: Genzyme Corporation

C07D453/02 A61K31/439 A61K31/454 A61K38/47 C07D453/00

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 9,126,993
App. No.: 14/471,958
Granted: Sep 8, 2015
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.

Claims (2)

1. A compound represented by the following structural formula,

or a pharmaceutically acceptable salt thereof.

Assignments (5)